Modules
Lakeside Diagnostic Labs, Corp.
Customer 15496
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ
- Assigned Reps
- Derek Callahan
- Website
- —
- Active Opportunity Count
- 2
- Published Count
- 1
- Revenue Base
- 17714.21
- Known GPBase
- 0
- Analyzer Platforms
- MicroGenics
- Product Groups
- MicroGenics
- Recommended Contact
- Holly Palladino
- Backup Contact
- Kara Lindqvist | | kara.lindqvist@lakesidediagnosticlabscorp.com | (949) 303-3815
- Last Meaningful Activity
- 2026-04-10
- Customer Memory
- Rep-entered/customer record note: shipping notes exist; verify details before shipment. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-8342ff0ef818fc795d071e8c9ae021af9b0b08152c1027e788c8c5b9232a7c82 | Customer 15496
Opportunities (3)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8342ff0ef818fc795d071e8c9ae021af9b0b08152c1027e788c8c5b9232a7c82 | OPP-ab55a42e1db705a31a860536d376dc1d1dbdb9e7dcddf4d60434cec8dcc9bf73 | SER-93dc2203e2470bd01c7e198521aac4895e499b6dc8d9e02db67130d1b9016a38 | Published | **** | **** | **** | Lakeside Diagnostic Labs, Corp. | 15496 | HQ | Hazard | KY | East | End-User Laboratory | High | — | — | — | — | — | — | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $16522.36; 215 days beyond expected account order date. | 8857.1 | 17714.21 | 26571.31 | — | — | — | 83.79 | High | False | True | — | CALL | Candidate CAND-8342ff0ef818fc795d071e8c9ae021af9b0b08152c1027e788c8c5b9232a7c82 | Customer 15496 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | OPP-88dd80fda1c83815a4809e591c26618df429a363a4451f07bf130c3c9c751a01 | SER-000afc4230a7284cd7bc5d0122f32fa7b5145ab5c876e6c78144664972cc9144 | Needs Validation | **** | **** | **** | Lakeside Diagnostic Labs, Corp. | 15496 | HQ | Hazard | KY | East | End-User Laboratory | High | MicroGenics | MicroGenics | T-10028872 | Thermo DRI Fentanyl II 115mL | — | 49560 | 3 completed purchases over 211 days; median interval 105.5 days; expected reorder 2026-03-26; High Risk by 137 days. | 2239.35 | 2985.8 | 3732.25 | 638.54 | 851.38 | 1064.23 | 69.22 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | Customer 15496 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | OPP-88dd80fda1c83815a4809e591c26618df429a363a4451f07bf130c3c9c751a01 | SER-000afc4230a7284cd7bc5d0122f32fa7b5145ab5c876e6c78144664972cc9144 | — | **** | — | — | Lakeside Diagnostic Labs, Corp. | 15496 | HQ | — | KY | — | — | — | MicroGenics | — | — | — | — | — | 3 completed purchases over 211 days; median interval 105.5 days; expected reorder 2026-03-26; High Risk by 137 days. | — | 2985.8 | — | — | 851.38 | — | 69.22 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | Customer 15496 |